SIMULTANEOUS REDUCTION IN BOTH A1C AND BODY WEIGHT WITH CANAGLIFLOZIN VERSUS GLIMEPIRIDE IN METFORMIN-TREATED PATIENTS WITH TYPE 2 DIABETES OVER 104 WEEKS
AACE ePoster Library. Leiter L. 05/13/15; 97787; 234
Dr. Lawrence Leiter
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
{{ help_message }}
{{filter}}